Evaluating Quantum (QMCO) After Debt Terminations And Stronger Than Expected Quarterly Guidance

Quantum (QMCO) is drawing attention after a cluster of capital structure moves, including terminating a term loan, canceling secured convertible notes, and moving to end a standby equity purchase agreement, alongside updated fourth quarter revenue guidance.

See our latest analysis for Quantum.

Quantum's recent debt repayments and positive fourth quarter revenue guidance help explain why the stock has a 90 day share price return of 147.56% and a 1 year total shareholder return of 19.47%, even though the 5 year total shareholder return is down 91.58%.

If you are watching Quantum's moves around data infrastructure and storage, it can be useful to widen your view with other AI related opportunities through 48 AI infrastructure stocks

With Quantum clearing debt, raising fresh equity at US$9.42 per share, and guiding fourth quarter revenue above its prior range, the question now is whether the recent 90 day surge leaves the stock undervalued or already pricing in future growth.

Advertisement

Most Popular Narrative: 41.1% Overvalued

The most followed narrative pegs Quantum's fair value at $9, which sits well below the last close at $12.70. That gap hinges on some firm assumptions about future earnings power and margins.

Although Quantum is targeting AI and high performance computing workloads through its partnership with Entanglement and positions its storage as a fabric for AI data centers, the company still carries about US$6 million of quarterly interest expense and relies on shareholder approval of a US$52 million debt exchange, so any delay in AI related deployments could prolong pressure on net income.

Read the complete narrative.

Curious what kind of revenue profile and margin rebuild are baked into that $9 fair value, and how long it assumes losses persist before turning into consistent earnings? The narrative leans on specific revenue trends, a step change in profitability and a future earnings multiple that is very different to where the stock sits today.

Result: Fair Value of $9 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this bearish setup could crack if Quantum converts its US$52 million term debt as planned, or if it starts clearing that US$25 million backlog more quickly.

Find out about the key risks to this Quantum narrative.

Another View: Cash Flows Point the Other Way

While the $9 fair value narrative focuses on future earnings and margins, the SWS DCF model presents a different picture. It estimates a future cash flow value of $34.67 per share versus the current $12.70 price, which implies that Quantum may be trading at a steep discount. This raises the question: which story is more persuasive, earnings or cash flows?

Look into how the SWS DCF model arrives at its fair value.

QMCO Discounted Cash Flow as at Jun 2026
QMCO Discounted Cash Flow as at Jun 2026

Next Steps

Given the mixed signals around Quantum's valuation, it makes sense to look under the hood yourself and move quickly while sentiment is shifting. A good place to start is by weighing the 2 key rewards and 4 important warning signs.

Looking for more investment ideas?

If you stop with just one stock, you might miss other opportunities that fit your targets even better, so keep scanning the market before you commit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Quantum might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGM:QMCO

Quantum

Provides data management solutions for unstructured data in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Moderate risk and fair value.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
48 users have followed this narrative
2 users have commented on this narrative
8 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7720.1% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
83 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
188 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0